These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38314781)

  • 21. The Role of Immunosuppression in the Development of COVID-19 in Systemic Lupus Erythematosus Patients: A Brief Report.
    Damirchi M; Aghaie M; Sedighi S; Tavassoli S; Roshandel G; Hassani M; Abdolahi N
    Iran J Med Sci; 2023 Jan; 48(1):91-97. PubMed ID: 36688192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe pneumonia in Chinese patients with systemic lupus erythematosus.
    Peng L; Wang Y; Zhao L; Chen T; Huang A
    Lupus; 2020 Jun; 29(7):735-742. PubMed ID: 32403979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study.
    Jiang X; Sparks J; Wallace Z; Deng X; Li H; Lu N; Xie D; Wang Y; Zeng C; Lei G; Wei J; Zhang Y
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36889799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the COVID-19 pandemic on SLE.
    Zhao X; Wu H; Li S; Gao C; Wang J; Ge L; Song Z; Ni B; You Y
    Mod Rheumatol; 2024 Feb; 34(2):247-264. PubMed ID: 36961736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
    Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
    J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
    Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
    J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
    Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
    Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort.
    Li M; Liang J; Pan W; Liu L; Wu M; Ding F; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Wen L; Zhang H; Sun L
    Clin Rheumatol; 2022 Nov; 41(11):3355-3362. PubMed ID: 35849245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical characteristics and risk factors of patients with systemic lupus erythematosus and cancer].
    Guo JY; Ren ZG; Xuan YY; Li TF; Liu XJ; Niu CZ; Li JY; Liu SY
    Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):218-221. PubMed ID: 32146749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of SLE patients with symptomatic COVID-19: Single centre experience at Sultan Qaboos University Hospital over a 30-month period.
    Hassan KS; Al Lawati B; Rizvi GA
    Lupus; 2023 Sep; 32(10):1173-1178. PubMed ID: 37471705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of new-onset systemic lupus erythematosus during pregnancy in Central China: a retrospective study of 68 pregnancies.
    He X; Jiang D; Wang Z; Li Y; Wang J; Xu D; Chen J; Liu X; Gao G
    Clin Rheumatol; 2021 Jun; 40(6):2121-2131. PubMed ID: 33064224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and associated factors of abdominal pain in systemic lupus erythematosus.
    Yuan S; Lian F; Chen D; Li H; Qiu Q; Zhan Z; Ye Y; Xu H; Liang L; Yang X
    J Rheumatol; 2013 Dec; 40(12):2015-22. PubMed ID: 24187097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance.
    Tan SYS; Yee AM; Sim JJL; Lim CC
    Rheumatology (Oxford); 2023 May; 62(5):1757-1772. PubMed ID: 36271852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    He F; Luo Q; Lei M; Fan L; Shao X; Hu K; Qin S; Yu N; Cao J; Yang L
    Clin Rheumatol; 2020 Sep; 39(9):2803-2810. PubMed ID: 32725351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study.
    González-Naranjo LA; Coral-Enríquez JA; Restrepo-Escobar M; Muñoz-Vahos CH; Jaramillo-Arroyave D; Vanegas-García AL; Eraso R; Vásquez G; Jaimes F
    Clin Rheumatol; 2021 Jan; 40(1):181-191. PubMed ID: 32529420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study.
    Cui HW; Lei RY; Zhang SG; Han LS; Zhang BA
    Lupus; 2019 Jul; 28(8):961-969. PubMed ID: 31208267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
    Su L; Qi Z; Guan S; Wei L; Zhao Y
    Front Immunol; 2022; 13():978910. PubMed ID: 36238309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 and Systemic Lupus Erythematosus.
    Thanou A; Sawalha AH
    Curr Rheumatol Rep; 2021 Jan; 23(2):8. PubMed ID: 33511495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.